Form 4: Ionis Pharmaceuticals Director Receives Stock Grant
Insider Transaction (Form 4)
Ludwig Hantson, a Director of Ionis Pharmaceuticals Inc, received 3,399 shares of common stock on July 15, 2026.
Summary
- Grant/award: acquired 3,399 Restricted Stock Unit on July 15, 2026; holds 3,399 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Ludwig Hantson — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-15 | Grant/award | Restricted Stock Unit | 3,399 | — | — | 3,399 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-15 | Grant/award (3,399 shares) |
Keywords
insider transaction, Form 4, IONS, IONIS PHARMACEUTICALS INC, neutral, Ludwig Hantson
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.